心泰医疗 02291Prospectus Information

Prospectus Information
IPO Timeline
Broker Results (T-2)
2022-11-04
Some brokers release in afternoon
Grey Market (T-1)
2022-11-07
Afternoon
HKEX Allotment (T-1)
2022-11-07
Evening
Registrar Allotment (T-1)
2022-11-07
Evening
Listing Day (T)
2022-11-08
First day of trading
Company Overview
Stock Name心泰医疗
Stock Code02291
Company Full Name心泰医疗
Industry醫療保健
Principal Activities主要從事研發、生產及商業化心臟病介入醫療器械。
Listing Date2022-11-08
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市松江區莘磚公路258號41幢1樓、5樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.scientechmed.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 29.15 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share29.7%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 65,470,900
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 1,000 HK$ 29,150
2 lots 2,000 HK$ 58,300
3 lots 3,000 HK$ 87,450
4 lots 4,000 HK$ 116,600
5 lots 5,000 HK$ 145,750
6 lots 6,000 HK$ 174,900
7 lots 7,000 HK$ 204,050
8 lots 8,000 HK$ 233,200
9 lots 9,000 HK$ 262,350
10 lots 10,000 HK$ 291,500
20 lots 20,000 HK$ 583,000
30 lots 30,000 HK$ 874,500
50 lots 50,000 HK$ 1,457,500
100 lots 100,000 HK$ 2,915,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
200 lots 200,000 HK$ 5,830,000
300 lots 300,000 HK$ 8,745,000
1,123 lots 1,123,000 HK$ 32,735,450
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 29.15
First Day OpenHK$ 29.8
First Day Change-62.09%
First Day Volume3807000.0
First Day Turnover111634000.0
Use of Proceeds
Use of Proceeds1、約50.7%(或約287.6百萬港元)將用于為未來五年內的研發活動提供資金; 2、約24.3%(或約137.9百萬港元)將用于未來五年內的銷售及營銷活動; 3、約5.0%(或約28.4百萬港元)將用于在未來五年內提升產能及加強制造能力; 4、約10.0%(或約56.7百萬港元)將用于為未來五年內潛在的戰略投資及收購提供資金,以補充和擴大我們的產品組合及技術; 5、約10.0%(或約56.7百萬港元)將用于營運資金及一般公司用途。
Underwriting Syndicate
Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (1)
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (5)
中国国际金融香港证券有限公司 CE AEN894 中信里昂证券有限公司 CE AAB893 中国银河国际证券(香港)有限公司 CE AXM459 华泰金融控股(香港)有限公司 CE AOK809 华盛资本证券有限公司 CE AUL711
Joint Lead Managers (5)
中国国际金融香港证券有限公司 CE AEN894 中信里昂证券有限公司 CE AAB893 中国银河国际证券(香港)有限公司 CE AXM459 华泰金融控股(香港)有限公司 CE AOK809 华盛资本证券有限公司 CE AUL711
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Harvest International Premium Value (Secondary Market) Fund SPC 78,471,800 HKD 11.99% 6 months 2023-05-08
2 九州通国际集团有限公司 39,235,900 HKD 5.99% 6 months 2023-05-08
3 上海临港经济发展集团投资管理有限公司 76,897,700 HKD 11.75% 6 months 2023-05-08
Directors & Management
Chairman陳娟
Company Secretary秦學;楊麗珊
No director data available.
Major Shareholders
Major Shareholders & Holdings樂普(北京)醫療器械股份有限公司(80.75%)
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics